91 related articles for article (PubMed ID: 28508693)
1. A metabolite profiling method for diagnosis of precancerous cervical lesions and HPV persistence.
Walker H; Burrell M; Flatley J; Powers H
Bioanalysis; 2017 Apr; 9(8):601-608. PubMed ID: 28508693
[TBL] [Abstract][Full Text] [Related]
2. ASC-US diagnosis and triage.
Del Mistro A
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S2-4. PubMed ID: 17727939
[No Abstract] [Full Text] [Related]
3. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
4. Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
Cuzick J; Du R; Adcock R; Kinney W; Joste N; McDonald RM; English K; Torres SM; Saslow D; Wheeler CM;
Gynecol Oncol; 2021 Sep; 162(3):555-559. PubMed ID: 34253387
[TBL] [Abstract][Full Text] [Related]
5. Detection of human papillomavirus DNA in patients referred to a family practice colposcopy clinic.
Holman JR
J Am Board Fam Pract; 1996; 9(3):162-6. PubMed ID: 8743228
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnosis of HPV infections].
Wentzensen N
Pathologe; 2011 Nov; 32(6):461-6. PubMed ID: 21845360
[TBL] [Abstract][Full Text] [Related]
8. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
9. Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypes.
Musa J; Taiwo B; Goldsmith S; Sutton S; Berzins B; Murphy RL
Arch Gynecol Obstet; 2011 Feb; 283(2):343-8. PubMed ID: 20229315
[TBL] [Abstract][Full Text] [Related]
10. Detection of 14 human papillomavirus genotypes in cervical samples in women from a central-southern area of Italy showing different Pap test results.
Zappacosta B; Romano L; Guerriero M; Graziano M; Vitrani A; De Ninno M; Carbone A
New Microbiol; 2009 Oct; 32(4):351-8. PubMed ID: 20128441
[TBL] [Abstract][Full Text] [Related]
11. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic significance of human papillomavirus overestimated].
Giard RW; Coebergh JW
Ned Tijdschr Geneeskd; 2003 Feb; 147(7):277-80. PubMed ID: 12622003
[TBL] [Abstract][Full Text] [Related]
13. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
[TBL] [Abstract][Full Text] [Related]
16. Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics.
Godoy-Vitorino F; Ortiz-Morales G; Romaguera J; Sanchez MM; Martinez-Ferrer M; Chorna N
PLoS One; 2018; 13(12):e0209936. PubMed ID: 30592768
[TBL] [Abstract][Full Text] [Related]
17. [Detection of multiple human papillomavirus infection in cervical specimens by flow fluorescent hybridization].
Chen QY; Bian ML; Zhang XY; Ou H; Ma L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):901-5. PubMed ID: 19671291
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
19. Screening for cervical cancer and human papilloma virus: Indian context.
Deodhar KK
Clin Lab Med; 2012 Jun; 32(2):193-205. PubMed ID: 22726999
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]